Tonight I'll be featuring the Hearts of Oak interview with retired Pfizer vice president and chief scientist Mike Yeadon — who confirms your worst suspicions, and offers some hope for humanity.
Mike Yeadon: The Benefit of the Doubt
Mike Yeadon: The Benefit of the Doubt
Mike Yeadon: The Benefit of the Doubt
Tonight I'll be featuring the Hearts of Oak interview with retired Pfizer vice president and chief scientist Mike Yeadon — who confirms your worst suspicions, and offers some hope for humanity.